Protagonist Therapeutics, Inc Earnings Per Share Diluted

Quick Answer

Protagonist Therapeutics, Inc reported Earnings Per Share Diluted of $2.05 (loss) per share for the year ending 2025.

  • Protagonist Therapeutics, Inc showed a decrease of -148.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Protagonist Therapeutics, Inc's annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Protagonist Therapeutics, Inc's Earnings Per Share Diluted has declined by 6.8%.
  • Historical annual values: Fiscal year 2025: $2.05 (loss) per share | Fiscal year 2024: $4.23 per share | Fiscal year 2023: $1.39 (loss) per share | Fiscal year 2022: $2.60 (loss) per share | Fiscal year 2021: $2.71 (loss) per share | Fiscal year 2020: $1.92 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: